헬스케어 분야 블록체인 기술 시장 : 컴포넌트별, 데이터 스토리지 아키텍처별, 용도별, 최종 사용자별, 도입 형태별, 조직 규모별 시장 예측(2026-2032년)

The Blockchain Technology in Healthcare Market is projected to grow by USD 30.17 billion at a CAGR of 14.50% by 2032.

Blockchain technology in healthcare is moving from proof-of-concept experimentation to targeted deployment across data exchange, drug traceability, clinical research, claims administration, provider credentialing, and patient consent management. The technology's core value is not replacing electronic health records, but creating tamper-evident, time-stamped, and permissioned trust layers around fragmented healthcare workflows.

Demand is being shaped by measurable pressures: healthcare remains one of the most expensive sectors for data breaches, IBM's 2024 Cost of a Data Breach Report identified healthcare as the highest-cost industry for the 14th consecutive year, and the WHO has reported that 1 in 10 medical products in low- and middle-income countries is substandard or falsified. These realities are increasing interest in blockchain-based healthcare data security, pharmaceutical supply chain verification, digital identity, and interoperable audit trails.

Transformative Shifts in the Healthcare Blockchain Landscape

The healthcare blockchain landscape is shifting from broad enterprise blockchain claims toward practical, standards-aligned use cases. Permissioned blockchain networks are gaining preference because they allow regulated organizations to define governance, access rights, data residency, and auditability while avoiding the privacy risks of placing protected health information directly on-chain.

Regulatory and industry mandates are accelerating adoption. The U.S. Drug Supply Chain Security Act, the EU Falsified Medicines Directive, unique device identification requirements, HL7 FHIR adoption, and privacy frameworks such as HIPAA and GDPR are strengthening the need for verifiable data provenance. As a result, healthcare organizations are focusing on off-chain data storage with on-chain hashes, smart contracts for workflow automation, and verifiable credentials for trusted exchange.

Cumulative Impact of Artificial Intelligence on Blockchain Adoption

Artificial intelligence is increasing the strategic relevance of blockchain in healthcare by expanding the volume, sensitivity, and value of clinical and operational data. AI models used in diagnostics, population health, medical imaging, drug discovery, and revenue cycle management require trusted data lineage, consent evidence, and model governance to reduce bias, protect privacy, and support regulatory review.

Blockchain can strengthen AI-enabled healthcare by recording dataset provenance, consent status, access events, and model audit trails without exposing raw patient data. It also complements privacy-preserving technologies such as federated learning, secure multiparty computation, and zero-knowledge proofs. The cumulative impact is a more accountable healthcare AI ecosystem in which data can be shared, validated, and monetized with stronger safeguards.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

North America leads in healthcare blockchain commercialization due to advanced digital health infrastructure, high healthcare spending, strong cybersecurity pressure, and regulatory focus on interoperability and drug traceability. The United States is shaped by HIPAA, DSCSA, ONC interoperability rules, and a large payer-provider-technology ecosystem, while Canada emphasizes provincial health data governance and secure identity frameworks.

Europe is advancing through GDPR-driven privacy requirements, the European Health Data Space, and established medicine verification systems under the EU Falsified Medicines Directive. Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Australia, and ASEAN economies digitize health records, telehealth, insurance, and pharmaceutical logistics. Latin America, including Brazil and Mexico, is adopting blockchain selectively for medicine authentication, claims transparency, and public health modernization, while the Middle East is supported by national digital health strategies, smart hospital investments, and secure health data platforms across GCC countries. Africa shows targeted potential in anti-counterfeit medicines, vaccination records, donor-funded health programs, and identity-linked access to care, particularly where fragmented infrastructure and trust gaps remain pronounced.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

Among major economic and policy groups, the G7 is a leading demand center because its members combine mature healthcare systems, strict privacy laws, high pharmaceutical innovation, and active AI governance. The European Union is especially influential through GDPR, the European Health Data Space, and cross-border digital identity initiatives that favor verifiable and consent-driven data exchange.

BRICS markets are important for scale, as China and India are investing heavily in digital health infrastructure and pharmaceutical traceability, while Brazil, Russia, and South Africa face incentives to strengthen public health data integrity and supply chain assurance. ASEAN presents a fast-growing opportunity as member states expand universal health coverage, e-pharmacy, and regional logistics. GCC countries are investing in smart hospitals, national health data platforms, and secure digital identity, while NATO members' cybersecurity priorities reinforce demand for resilient healthcare infrastructure, protected medical supply chains, and trusted data exchange across defense-linked and civilian health systems.

Key Country Insights Across Major Healthcare Blockchain Markets

The United States remains the most commercially mature market for blockchain technology in healthcare due to DSCSA traceability requirements, large-scale payer complexity, HIPAA compliance needs, ONC interoperability rules, and strong digital health investment. Canada is advancing through secure data-sharing and provincial interoperability programs, while Mexico and Brazil show opportunity in pharmaceutical authentication, insurance workflows, and public health modernization.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are influenced by privacy-first data exchange, medicine verification, electronic health record modernization, and broader digital health programs aligned with GDPR principles. Russia's market is shaped by domestic digital infrastructure, data localization priorities, and pharmaceutical control systems. In Asia-Pacific, China and India offer scale in health data platforms, e-pharmacy, public insurance digitization, and anti-counterfeit measures; Japan, South Korea, and Australia emphasize secure interoperability, medical research, advanced hospital systems, and high-trust digital identity in mature healthcare environments.

Actionable Recommendations for Healthcare Blockchain Leaders

Industry leaders should prioritize blockchain use cases where the technology solves a provenance, audit, or multi-party coordination problem. High-value starting points include drug traceability, clinical trial consent, provider credentialing, claims reconciliation, medical device lifecycle tracking, and patient-mediated data access.

Organizations should avoid storing protected health information directly on-chain and instead use privacy-preserving architecture that combines off-chain repositories, tokenized permissions, cryptographic hashes, and role-based access. Successful deployment requires governance before technology: define network participants, liability, data standards, smart contract controls, cybersecurity protocols, and compliance obligations. Leaders should align with HL7 FHIR, DSCSA, GDPR, HIPAA, and local health data rules from the outset.

Research Methodology for Healthcare Blockchain Analysis

This executive summary is developed using a secondary research-led methodology aligned with market intelligence best practices. The analysis synthesizes information from recognized public health agencies, regulatory frameworks, industry standards bodies, cybersecurity studies, pharmaceutical traceability requirements, and digital health policy initiatives.

Key reference areas include WHO guidance on falsified medicines, IBM healthcare breach cost reporting, U.S. DSCSA implementation, EU Falsified Medicines Directive requirements, GDPR, HIPAA, HL7 FHIR interoperability standards, W3C decentralized identity and national digital health strategies. Insights are validated through triangulation across regulatory evidence, technology adoption trends, healthcare workflow needs, and observed enterprise deployment patterns.

Conclusion: Blockchain as a Trust Layer for Digital Healthcare

Blockchain technology in healthcare is becoming a practical trust infrastructure for an increasingly digital, AI-enabled, and regulated sector. Its strongest applications are emerging where healthcare stakeholders need shared verification without surrendering control of sensitive data.

The next phase of blockchain adoption in healthcare will favor permissioned networks, privacy-preserving design, compliance-ready interoperability, and measurable operational outcomes. Organizations that connect blockchain with AI governance, pharmaceutical integrity, patient consent, and secure health data exchange will be best positioned to reduce risk, improve transparency, and build resilient healthcare ecosystems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Blockchain Technology in Healthcare Market, by Component

• 7.1. Platforms
  • 7.1.1. Consortium Ledgers
  • 7.1.2. Hybrid Ledgers
  • 7.1.3. Private Ledgers
  • 7.1.4. Public Ledgers
• 7.2. Services
  • 7.2.1. Consulting Services
  • 7.2.2. Integration And Deployment
  • 7.2.3. Support And Maintenance
  • 7.2.4. Training And Education

8. Blockchain Technology in Healthcare Market, by Data Storage Architecture

• 8.1. On Chain Storage
• 8.2. Off Chain Storage
• 8.3. Hybrid Storage

9. Blockchain Technology in Healthcare Market, by Application

• 9.1. Claims Management
• 9.2. Clinical Trials
• 9.3. Credential Management
• 9.4. Identity Management
• 9.5. Patient Data Management
• 9.6. Supply Chain Management

10. Blockchain Technology in Healthcare Market, by End User

• 10.1. Hospitals And Clinics
• 10.2. Insurance Providers
• 10.3. Patients
• 10.4. Pharmaceutical Companies
• 10.5. Research Institutions

11. Blockchain Technology in Healthcare Market, by Deployment Mode

• 11.1. Cloud
  • 11.1.1. Hybrid Cloud
  • 11.1.2. Private Cloud
  • 11.1.3. Public Cloud
• 11.2. On Premises

12. Blockchain Technology in Healthcare Market, by Organization Size

• 12.1. Large Enterprises
• 12.2. Small And Medium Enterprises

13. Blockchain Technology in Healthcare Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Blockchain Technology in Healthcare Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Blockchain Technology in Healthcare Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Akiri, Inc.
• 17.2. BurstIQ, LLC
• 17.3. Chronicled, Inc.
• 17.4. Consensys
• 17.5. Doc.AI, Inc. by Sharecare
• 17.6. Embleema, Inc.
• 17.7. EncrypGen
• 17.8. Guardtime AS
• 17.9. Hashed Health, LLC
• 17.10. HealthVerity, Inc.
• 17.11. Infosys Limited
• 17.12. International Business Machines Corporation
• 17.13. iSolve, LLC
• 17.14. Medicalchain SA
• 17.15. Microsoft Corporation
• 17.16. Nebula Genomics
• 17.17. Oracle Corporation
• 17.18. Patientory, Inc.
• 17.19. ProCredEx, Inc.
• 17.20. The SyncWork Group, Inc.
• 17.21. Virtusa Corporation
• 17.22. Wipro Limited